Results per Page:
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Pediatric cancer survivors have a higher risk of chronic health conditions
From Dr. Wendy Liesenring, Clinical Research Division
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium
First Lady Jill Biden: ‘Your work will change and save lives’
MET-X research lab tour and Cancer Moonshot ‘listening session’ on survivorship and pediatric cancer highlight First Lady's visit to Fred Hutch
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Pediatric cancer disparities in Washington State
From the Chow Group, Clinical Research Division
Matthew’s story: the power of positivity helps one childhood cancer patient
Matthew had proton therapy after several surgeries for craniopharyngioma.
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Liver cancer researcher Dr. Abir Arfaoui named latest Brave Fellow
Running community honors late athlete Gabe Grunewald by funding rare cancer research at Fred Hutch
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?